LUMOS: Latent Universal Medical Priors for Segmentation

Abstract

General vision foundation models (VFMs) have been primarily developed on natural images, and their utility for medical image segmentation is therefore often considered to depend on costly adaptation or domain-specific fine-tuning. In this paper, we revisit this assumption from a different perspective: rather than requiring VFM segmentors to relearn visual regularities, we investigate whether the low-level visual priors necessary for anatomical delineation already lie dormant within general VFMs. We observe that frozen VFMs, despite lacking medical supervision, encode transferable visual regularities. These properties are not exclusive to natural images but are also fundamental to medical image understanding. Motivated by this observation, we propose Latent Universal Medical PriOrs for Segmentation (LUMOS), a novel framework that amplifies general VFM priors to conventional medical segmentors. LUMOS consists of two key components: (1) Pathfinder that distills visual cues from a frozen vision foundation model, and (2) Inspiror that sparks the conventional medical networks with spatial guidance from distilled visual regularities. In this way, the segmentor is relieved from learning complex visual regularities entirely from limited medical annotations and can instead focus on task-specific anatomical delineation. Across diverse medical datasets and token-based VFMs, LUMOS shows that general VFMs can serve as spatial prior generators when their frozen token spaces preserve patch-level pattern relevance. DINO provides stable matched-backbone gains, while SigLIP exposes VFM-specific sensitivity caused by its different token granularity and representation objective.

0

Turn this paper into a full lesson

ArcXiv compiles a staged curriculum from this paper: 8-12 lessons across beginner → advanced, synthesised section guides, visuals, flashcards, a quiz, exercises, and on-demand deep dives per section. Grounded in the abstract, never invented.

Discussion (0)

Sign in to join the discussion.

Loading comments…